Subject Matter: Retrospective:
|
Bayer Inc. has a number of subject matters of interest related to our health care (animal health, biologicals, consumer care, diagnostics, pharmaceuticals) and material science businesses. These include regulations under the Food and Drugs Act, including Health Canada's regulatory renewal initiative, Canada's environmental policy, including the review of CEPA, consultations relating to the Patented Medicine Prices Review Board's mandate and policies, the federal Science and Technology Strategy and consultations on Canada's budget and taxation, including SR&ED tax credits.
|
Subject Matter: Prospective:
|
Bayer Inc. has a number of subject matters of interest related to our health care (animal health, biologicals, consumer care, diagnostics, pharmaceuticals) and material science businesses. These include regulations under the Food and Drugs Act, including Health Canada's regulatory renewal initiative, Canada's environmental policy, including the review of CEPA, consultations relating to the Patented Medicine Prices Review Board's mandate and policies, the federal Science and Technology Strategy and consultations on Canada's budget and taxation, including SR&ED tax credits.
|